RBFOX3 and Cerebral ischemia: In conclusion, while our experiments provide a strong experimental basis for the use of IA treatment after cerebral ischemia reperfusion injury, further studies utilizing triple immunofluorescence are needed to assess whether all three of our cell markers (Brdu, β-catenin, and NeuN) are colocalized and whether new neurons replace the function of necrotic tissue.